What is Somalytics?
Founded in 2021 and headquartered in Redmond, Washington, Somalytics is at the forefront of developing advanced sensing capabilities for the digital world. The company is commercializing a patent-pending carbon-nanotube paper composite (CPC) capacitive sensor, a novel technology originating from research at the University of Washington in collaboration with CoMotion. These miniature and highly sensitive sensors are designed for applications in eye tracking, consumer electronics, AR/VR, the Internet of Things, health and wellness, and transportation, aiming to enhance human-computer interaction and user experiences across various industries.
How much funding has Somalytics raised?
Somalytics has raised a total of $1.9M across 1 funding round:
Angel/Seed
$1.9M
Angel/Seed (2022): $1.9M with participation from IP Group and WRF Capital
Key Investors in Somalytics
IP Group
IP Group is a conglomerate specializing in intellectual property commercialization, supporting innovative ventures from university partnerships with business expertise and capital investment.
WRF Capital
WRF Capital, part of the Washington Research Foundation, is an early-stage investor focused on transforming innovative ideas from local research institutions into successful businesses, particularly in life sciences and technology.
What's next for Somalytics?
With a major enterprise-level funding context and a recent strategic investment, Somalytics is poised for significant scaling and market penetration. The company's focus on developing highly sensitive, miniature sensors for diverse high-growth sectors suggests a strategic roadmap centered on product development, market expansion, and potential strategic partnerships. This capital infusion will likely accelerate the commercialization of their CPC sensor technology, enabling Somalytics to solidify its position in the competitive landscape of advanced sensor solutions and IoT innovation.
See full Somalytics company page
